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Introduction
Many enzymes are activated by specific binding of one or
more monovalent cations (MVCs); these either contribute di-
rectly to the catalysis at the active site or indirectly modulate
the activity by binding to an allosteric site. Potassium and
sodium ions are the most common activating MVCs, with
a strong correlation between MVC preference and intracellular
(K+) or extracellular (Na+) location of the enzyme.[1] Examples
of intracellular, potassium-activated enzymes are the molecular
chaperones Hsp70[2] and GroEL[3] (K+ binding at the active sites
is crucial for the ATP-dependent reaction cycles), ribokinase
(K+ binding near but not at the active site activates the
enzyme),[4] and the hydrolase histone deacetylase 8 (HDAC8;
binding to two K+ binding sites affects activity).[5] It is general-
ly found that enzymes that are activated by the binding of K+
(ionic radius 1.33 ) are either not activated or are activated to
a lesser extent by Na+ (ionic radius 0.97 ), and vice versa.
However, enzymes that are activated by K+ can often be acti-
vated by an MVC of similar ionic radius, such as Rb+ (1.48 )
or NH4
+ (1.44 ).[6] In some cases it has even been possible to
engineer a potassium-independent enzyme by introducing
a lysine residue in such a way that its terminal R-NH3
+ occu-
pies the binding site, thereby taking the place of the regulato-
ry potassium ion.[7]
Using NH4
+ as a proxy for K+ offers the opportunity to char-
acterise potassium binding sites by NMR spectroscopy, as
isotopically labelled 15NH4
+ is readily available and can be em-
ployed in combination with conventional heteronuclear solu-
tion-state NMR experiments. The use of 15NH4
+ as a K+ mimic
has been reported previously for the characterisation of potas-
sium binding sites of DNA quadruplexes[8] by NMR spectrosco-
py. However, the previously investigated DNA quadruplexes
are relatively small compared to many enzymes, and quadru-
plexes also exhibit highly symmetric MVC binding sites. It is
therefore not immediately obvious that the approach of using
15NH4
+ to probe potassium binding sites will also be applicable
to larger, potassium-dependent enzymes.
Herein we show that 15NH4
+ can be used to probe K+ bind-
ing sites in medium-sized enzymes (>40 kDa) by NMR spec-
troscopy. The technique is facilitated by local reorientation and
cross-correlated relaxations of the symmetric 15NH4
+ molecule
within its binding site; this results in line-narrowing of the 15N
and 1H resonances, thereby improving the sensitivity of hetero-
nuclear NMR experiments. In contrast to other experimental
approaches used to probe MVC binding sites in proteins, NMR
measurements of 15NH4
+ have distinct advantages: 1) these
probe the binding of the MVC directly, not indirectly (e.g. , by
enzyme activity or stability) ; 2) they have a high spatial resolu-
tion (in contrast to, for example, fluorescence spectroscopy) ;
3) they cause relatively little perturbation (unlike site-directed
mutagenesis-based experiments); and 4) they are suitable for
monitoring weak binding events (up to the high mm range),
where other methods to study MVC binding (e.g. , isothermal
titration calorimetry) have limitations.[9]
A variety of enzymes are activated by the binding of potassium
ions. The potassium binding sites of these enzymes are very
specific, but ammonium ions can often replace potassium ions
in vitro because of their similar ionic radii. In these cases, am-
monium can be used as a proxy for potassium to characterise
potassium binding sites in enzymes: the 1H,15N spin-pair of
enzyme-bound 15NH4
+ can be probed by 15N-edited heteronu-
clear NMR experiments. Here, we demonstrate the use of NMR
spectroscopy to characterise binding of ammonium ions to
two different enzymes: human histone deacetylase 8 (HDAC8),
which is activated allosterically by potassium, and the bacterial
Hsp70 homologue DnaK, for which potassium is an integral
part of the active site. Ammonium activates both enzymes in
a similar way to potassium, thus supporting this non-invasive
approach. Furthermore, we present an approach to map the
observed binding site onto the structure of HDAC8. Our
method for mapping the binding site is general and does not
require chemical shift assignment of the enzyme resonances.
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The critical point is that the binding of 15NH4
+ to an MVC
binding site can decrease the exchange of the ammonium pro-
tons with the bulk solvent to such an extent that these
become observable even under conditions where free 15NH4
+
in solution is undetectable in proton–nitrogen-correlated ex-
periments because of rapid exchange with the solvent.
For the HDAC8 enzyme, we first show that ammonium and
potassium regulate the activity similarly, thus supporting the
use of 15NH4
+ as a proxy for K+ . Using 15N-edited NMR meth-
ods, we probed the binding of 15NH4
+ to one of the potassium
binding sites of HDAC8 and to two potassium binding sites of
the bacterial Hsp70 homologue DnaK. Furthermore, we devel-
oped a strategy for mapping potassium binding sites within
protein structures that does not require a protein chemical
shift assignment. The strategy relies on selective isotope label-
ling, and utilises through-space NOE measurements between
15NH4
+ protons and residue-specific side-chain protons.
Results and Discussion
Binding of ammonium to HDAC8
The 42 kDa human HDAC8 enzyme is activated by the binding
of potassium ions.[5] In addition to the catalytically important
Zn2+ ion at the active site, crystal structures of HDAC8 reveal
two MVC binding sites (Figure 1A–C), as has been observed in
most structurally characterised HDACs and HDAC-related de-
acetylases.[10] Biochemical characterisation[5] and computational
approaches[11] have highlighted the importance of potassium
binding for activity and potentially even for regulation of this
enzyme. Specifically, the effect of KCl concentration on HDAC8
activity was investigated by Fierke and co-workers using
HDAC8 with two different divalent metal ions (Co2+ and Zn2+)
bound at the active site.[5] These experiments revealed a bell-
shaped activity profile, with an activating effect at lower con-
centrations of K+ and an inactivating effect as the concentra-
tion was increased. The resulting activation (K1/2,act) and inhibi-
tion (K1/2,inhib) constants, which describe the apparent dissocia-
tion constants for an activating and an inhibiting binding site,
respectively, were K1/2,act=14 mm and K1/2,inhib=130 mm for
Zn2+-bound HDAC8.
In order to test whether NH4
+ is a good mimic of K+ for
enzyme activation, we measured the deacetylase activity of
HDAC8 as a function of NH4
+ , K+ and choline concentration.
Choline was used as a negative control to detect any possible
nonspecific influence of ionic strength on HDAC8 activity. For
K+ and NH4
+ the activity profiles were bell-shaped (Figure 1D),
similar to those reported previously, whereas addition of chol-
ine had only a very small effect on HDAC8 activity. NH4
+ acti-
vation of HDAC8 was ~60% of that of K+ , with comparable
K1/2,act (compare the curves in Figure 1D), thus suggesting that
NH4
+ effectively mimics K+ in modulating the activity of
HDAC8.
Next, we tested whether it was possible to observe binding
of 15NH4
+ to HDAC8 by NMR. As expected, bulk 15NH4
+ was
not observed in 15N-edited, proton-detected 1D NMR spectra
in buffer containing 200 mm 15NH4
+ at pH 8.0 (Figure 2A) be-
cause of rapid exchange of the ammonium protons with the
bulk solvent. The 15N chemical shift of the free ammonium was
therefore determined by direct 15N-detection to be 20.5 ppm
(Figure 2A, inset). Addition of [14N]HDAC8, however, resulted in
a distinct peak in the 15N-edited experiment, indicative of
HDAC8-bound 15NH4
+ with a proton chemical shift of 7.1 ppm
(Figure 2B). A 15N chemical shift of 25.5 ppm was subsequently
determined by recording a 2D 1H,15N HSQC spectrum (Fig-
ure 2C).
The 15N line-width of 15NH4
+ at 298 K bound to HDAC8
(42 kDa) would be expected to be ~45 Hz, with the 15N nu-
cleus relaxed principally by dipolar interactions with its four
protons, with a rotational correlation time of approximately
25 ns. The observation of a peak in the 15N-edited spectra,
shifted from the position for free ammonium, shows that bind-
ing of the 15NH4
+ ion to HDAC8 is sufficiently strong to signifi-
cantly limit exchange of the ammonium protons with the bulk
solvent. Although cross-correlated relaxations within the
15NH4
+ molecule cause line-narrowing, the experimental line-
width (~25 Hz), which also includes contributions from the re-
sidual proton exchange and proton R1, indicates that the am-
monium ion is undergoing local reorientation within the bind-
ing site. The spectral parameters obtained from the peak in
the 15N-edited spectrum report directly on 15NH4
+ in the MVC
binding site, with the intensity of this peak directly related to
Figure 1. A) Crystal structure of HDAC8 (PDB ID: 2V5W) with the active-site
Zn2+ (black sphere) and the two K+ ions (purple spheres). B) Residues
within approximately 10  of the two potassium binding sites in HDAC8.
Histidine residues are shown in cyan. C) Two-dimensional representations of
the two binding sites (generated with Ligplot).[12] K+-coordinating residues
and atoms are labelled. D) Activity profile as a function of monovalent
cation concentration. Concentrations of K+ (red), NH4
+ (green) and choline+
(blue) were in 25 mm Tris·HCl at pH 8.0. The two-site binding model de-
scribed previously[5] was used to fit the activity profile for KCl and NH4Cl ac-
cording to the equation v=v1/(1+K1/2,act/[MVC]+ [MVC]/K1/2,inh), where K1/2,act
and K1/2,inh are the apparent binding affinities (dissociation constants) for ac-
tivation and inhibition, v is the relative kcat/KM value, v1 is the kcat/KM value of
the fully activated state and [MVC] is the concentration of the respective
monovalent cation. kcat/KM of the fully inhibited state was set as zero; data
are normalised such that v1 (K
+)=1.0. K1/2,act (K
+): 4526 mm, K1/2,inh (K+):
610530 mm, K1/2,act (NH4+): 258 mm, K1/2,inh (NH4+): 26001700 mm. Al-
though the errors for the affinities of the inhibitory site are large, these data
agree with a bell-shaped activity profile for K+ and NH4
+ .
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the amount of 15NH4
+ bound to HDAC8, thus allowing an esti-
mation of the dissociation constant.
Proton-detected, 15N-edited 1D spectra were recorded for a
titration of HDAC8 with 15NH4
+ , and the resulting 15NH4
+ peak
integrals were used to determine the dissociation constant for
binding of 15NH4
+ to HDAC8 (KD= (138) mm ; Figure 2D). Ad-
dition of 100 mm KCl to a sample containing 100 mm 15NH4
+
led to a reduction (~50%) in the 15NH4+ integral, thus indicat-
ing both that NH4
+ and K+ compete for the same binding site
and that they bind to this site with similar affinities (Fig-
ure 2D). We therefore conclude that NH4
+ binds to at least
one of the two K+ binding sites in HDAC8. Binding of NH4
+ to
this site decreased proton-exchange with the solvent to such
an extent that it was observable in 1H,15N-correlated experi-
ments, under conditions where bulk NH4
+ cannot be detected.
The change in 15N chemical shift upon binding (Dd=5 ppm)
indicates a significant change in the chemical environment,
and given the different natures of the two potassium binding
sites in HDAC8 (see below and Figure 1C), it is unlikely that
both the proton and 15N chemical shifts of the two HDAC8-
bound ammonium ions would be so similar as to lead to over-
lap of the corresponding peaks in the 1H,15N-correlated spectra.
We propose instead that HDAC8 binds a second
NH4
+—as it binds a second K+—but that this second
site does not protect the bound NH4
+ from solvent
proton exchange sufficiently to be detectable in our
experiments.
Binding of ammonium to DnaK
Another example of a potassium-binding enzyme is
the molecular chaperone Hsp70. Two potassium ions
in the ATP-binding domain (Figure 3A) have been
identified to be crucial for the ATPase cycle,[6b] which
in turn regulates the binding and release of substrate
proteins.[13] In a similar way to that for HDAC8, these
potassium ions can be replaced by ammonium,
thereby resulting in approximately half of the ATPase
activity observed with potassium.[6b] Based on our
success in characterising the potassium binding sites
of HDAC8 with 15NH4
+ , we tested the general applic-
ability of our approach by probing the potassium
binding sites of the 41 kDa ATP-binding domain of
DnaK, a bacterial Hsp70 homologue from Thermus
thermophilus.
Unlike for the experiments with HDAC8, addition
of nucleotide-free DnaK ATP-binding domain (DnaK-
ABD) to a 15NH4Cl-containing buffer gave only a very
weak signal in 15N-edited proton-detected and 1H,15N
correlation spectra. The signal was barely above the
noise level (Figure 3B, Figure S1B in the Supporting
Information), thus suggesting either that 15NH4
+
binds only weakly to nucleotide-free DnaK-ABD, or
that the binding sites are solvent-exposed and do
not shield the ammonium protons from exchange
with bulk solvent (Figure S1). Interestingly, addition
of ADP and Pi resulted in the appearance of two
Figure 2. A) 15N-edited 1D proton spectrum of the buffer (25 mm Tris·HCl pH 8.0, 200 mm
15NH4Cl, 0.5 mm TCEP) and direct
15N-detected 1D spectrum (inset). B) As above but after
addition of ~100 mm [14N]HDAC8 to the sample. C) 1H,15N HSQC spectrum of the sample
shown in B). D) Titration of 15NH4
+ (*) with the observed binding site in HDAC8 (using
15N-edited 1D proton spectra). The intensities were obtained by integration of the am-
monium peak, and errors were estimated by a combination of integrating multiple noise
regions and by taking into account the uncertainties in calculating the relative protein
concentration. At 100 mm 15NH4
+ , addition of 100 mm KCl (~) led to approximately 50%
reduction of the signal, thus indicating that K+ and NH4
+ bind to the same site with sim-
ilar affinities. A hyperbolic binding equation Y=AX/(KD+X) (c) was fitted to the nor-
malised peak intensities to yield KD= (138) mm.
Figure 3. A) Crystal structure of the ATPase domain of Hsp70 (PDB ID:
1HPM):[2] purple spheres: K+ , green sphere: Mg2+ , yellow sticks: ADP and Pi.
A Ligplot analysis showing two-dimensional representations of the binding
sites is shown in Figure S2. B) 1H,15N HSQC spectra and 1D projections
(above) with the ABD of bacterial Hsp70 homologue DnaK. Red spectra:
DnaK-ABD (100 mm) in 30 mm Tris·HCl, 150 mm 15NH4Cl, 5 mm MgCl2 and
1 mm DTT, pH 7.5. Blue spectra: the same sample after addition of 0.5 mm
ADP and 50 mm 14NH4H2PO4. Note: because of the low pH of the
14NH4H2PO4
stock solution, Tris base was also added to achieve pH 7.5, thus increasing
the total Tris concentration to 75 mm.
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clear peaks (Figure 3B). The 15N chemical shifts of both these
peaks (19.3 and 21.9 ppm) are different from the 15N chemical
shift that we observed for free ammonium in this buffer when
using a direct-detect 15N experiment (20.6 ppm). Our interpre-
tation of these results is that binding of ADP and Pi protects
the ammonium protons from solvent exchange, by themselves
blocking solvent molecules and/or by inducing a conformation-
al change that decreases solvent accessibility. Both effects
agree well with molecular models of nucleotide binding to
Hsp70, and it is likely that a combination of both leads to the
increased protection of ammonium ions.[2,14]
To verify that the two resonances observed in Figure 3B
report on two different sites, we recorded 15N-edited NOESY
experiments (Figure S3). In the resulting 15N-edited NOESY
spectrum, the two resonances gave rise to very different sets
of cross-peaks, thus confirming that the resonances report on
two different sites in the protein, in agreement with the obser-
vation of two different potassium binding sites in the crystal
structures of Hsp70 chaperones.
Mapping the MVC binding sites
The ammonium protons bound in a protein environment are
close to protons of nearby amino acid side chains; this proxim-
ity serves as a potential means for mapping the MVC binding
site within the protein structure. The key restraints used for
protein structure determinations are nuclear Overhauser en-
hancements (NOEs) between protons, where the intensity of
the observed NOE is approximately proportional to r6 (r is the
distance between the two interacting protons). Similarly, NOEs
between bound ammonium protons and protein side-chain
protons report on the location of the MVC binding site.
A 15N-edited NOESY experiment was performed to identify
side chains in the vicinity of the observed MVC binding site of
HDAC8. The resulting spectrum shows a number of NOE cross-
peaks between the HDAC8-bound ammonium and the aliphat-
ic side chains, as well as between the ammonium and the
amide protons (Figure 4). For proteins where a full chemical
shift assignment is available, the binding site is readily
mapped from the chemical shifts of the NOE cross-peaks. How-
ever, for HDAC8, as well as many other enzymes of interest,
a full chemical shift assignment is not available, so alternative
approaches must be used. Site-directed mutagenesis and mu-
tation of K+-binding side chains might be an initial and intui-
tive approach. However, such an approach fails for HDAC8, as
the potassium is mostly coordinated by the protein backbone,
and also because mutation of side chains that do participate in
the coordination of K+ (S199 and D176, see Figure 1C)[15] re-
sulted in insufficient purified protein for further NMR character-
isation. Generally, identification of MVC binding sites by site-
directed mutagenesis could prove difficult, as such sites are
either close to the active site or in allosteric regions of the
enzyme. Site-directed mutagenesis therefore easily leads to
large perturbations of the protein environment. We therefore
prefer a non-invasive approach (described below) that is based
on residue-specific isotope labelling.
Inspection of the two potassium binding sites in the HDAC8
crystal structure revealed different distributions of amino acids
in the immediate vicinities of the two binding sites. Whereas
the binding site close to the active site (here termed “site 1”) is
surrounded by histidines (Figure 1B and Figure 4) and leucines,
these amino acids are not found in the vicinity of site 2. We
therefore produced HDAC8 that was selectively protonated at
histidine side chains, by adding 1H,15N-labelled histidine in an
otherwise fully 2H,14N background. Histidine is at the end of
a biosynthetic pathway and therefore little scrambling with
other amino acids is expected.[16] This is confirmed by the fact
that we observed a maximum of 11 cross-peaks in the amide
region of a 1H,15N HSQC spectrum of this sample, compared to
13 histidines in HDAC8 (Figure S4). Although a specifically histi-
dine-labelled sample has aliphatic protons only in the histidine
side chains, additional protons are present at exchangeable
sites, such as unprotected backbone amides. To account for
exchangeable protons introduced by the H2O buffers, we ex-
Figure 4. 15N-edited NOESY experiments with different isotope labelling
schemes used to map the K+/NH4
+ binding site of HDAC8 (PDB ID:
2V5W[15]). Shaped 15N pulses at 25 ppm (see the Experimental Section) en-
sured selection of ammonium-specific cross-peaks. The fully protonated
HDAC8 sample (left, black) gives rise to many cross-peaks that arise from
the side chain and backbone protons of HDAC8 in the vicinity of the ammo-
nium binding site. Expressing HDAC8 in a medium supplemented with pro-
tonated histidine in an otherwise deuterated background (middle, blue) re-
duces the number of crosspeaks significantly. The only observed cross-peaks
in the aliphatic region are those from non-exchangeable histidine side-chain
protons. A control experiment shows HDAC8 expressed in deuterated
medium without labelled histidine supplement (right, red). Only solvent-ex-
changeable protons give rise to cross-peaks. The graph on the right shows
the distributions of expected chemical shifts for the exchangeable protons
in HDAC8 (red) and all histidine protons (blue) based on BMRB statistics. The
HDAC8 structures above the spectra (modelled from PDB ID: 2V5W) high-
light protons introduced by the corresponding labelling scheme in blue (his-
tidine), red (exchangeable) and grey (all). This set of experiments, in combi-
nation with the distribution of histidine residues, localises the observed am-
monium binding site in the HDAC8 structure.
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pressed and purified a sample (U-15N,2H) in the same deuterat-
ed background and without the addition of protonated histi-
dine. By comparing the results of the subsequent NOESY
experiments (Figure 4), we could clearly identify several cross-
peaks originating from histidine side chains. This demonstrates
that the observed NH4
+ binds to site 1, and thus we were able
to assign the observed K+/NH4
+ binding site in HDAC8 even
in the absence of a full chemical shift assignment.
In general, identification and assignment of MVC binding
sites is possible provided that 1) the corresponding 15NH4
+ is
sufficiently protected from solvent exchange that a signal is
observed in 15N-edited NMR spectra, and 2) the MVC binding
sites of interest have different local distributions of amino
acids.
Conclusions
We successfully used 15NH4
+ to characterise a K+ binding site
in the 42 kDa enzyme HDAC8 by NMR spectroscopy. By using
15NH4
+ instead of K+ , we could employ NOESY experiments in
combination with selective amino acid labelling of the protein
to probe the immediate vicinity of the binding site and map it
onto the HDAC8 structure. These experiments have advantag-
es over other means of characterising potassium binding sites
in proteins. Firstly, these experiments map the potassium bind-
ing sites with minimal perturbation. As HDAC8 has two bind-
ing sites for potassium and these are connected by one b-
strand, one would expect perturbations of these sites to have
mutual effects on each other. Chemical shift perturbations
upon titrating with K+ or assays based on site-directed muta-
genesis could therefore lead to ambiguous results. The assign-
ment of the sites by 15NH4
+-detected NOESY spectra does not
suffer from such ambiguity. Secondly, this strategy does not
rely on an available chemical shift assignment for the protein,
and is generally applicable provided a crystal structure is
known and the amino acid compositions of the binding sites
in question are different. And thirdly, most of the experiments
presented here do not require isotopically labelled protein
samples and are therefore relatively cost-effective compared to
many other experiments involving NMR spectroscopy.
The bell-shaped activity profile and the presence of two
MVC binding sites in crystal structures of HDAC8 led to
a model of one activating and one deactivating K+ binding
site. Combination of this model with site-directed mutagenesis
experiments has led to the proposition that occupation of the
K+ binding site close to the active site (site 1) is deactivating,
whereas occupation of the second site (site 2) is activating.[5]
Our results, however, suggest that site 1 is occupied even at
relatively low concentrations of K+ (15NH4
+ KD 13 mm), that
is, in the concentration range of enzyme activation. Recently,
we were able to show that binding of potassium has an effect
on the structural integrity of HDAC8 in a similar concentration
range (K+ KD42 mm) as probed by an arginine side chain
close to site 2 (~12  from site 2, 21  from site 1).[17]
Based on these findings, we therefore propose that both po-
tassium binding sites are important for the stabilisation and ac-
tivation of the enzyme, and we speculate that the deactivating
effect at higher potassium concentrations could result from
secondary effects, such as that of high ionic strength on KM or
inhibition by high concentrations of chloride.[6a]
In a second example, we monitored ammonium binding to
the 41 kDa ATP binding domain of the Hsp70 chaperone DnaK.
After addition of ADP and Pi, we observed two crosspeaks in
the 1H,15N HSQC spectrum, in agreement with the two potassi-
um ions observed in the crystal structure of Hsp70 with ADP
and Pi. These results are in agreement with previous findings
of a closed and less solvent-accessible active site in response
to nucleotide binding.[14a]
Overall, we detected three potassium binding sites in two
proteins by using 15NH4Cl and
15N-edited NMR spectra. The
observed chemical shifts range from 6.8 to 7.5 ppm in the 1H
dimension and from 19 to 25.5 ppm in the 15N dimension. The
level of dispersion suggests that this approach can be used to
observe and identify multiple potassium binding sites in even
large proteins, where the relaxation properties might be im-
proved by cross-correlated relaxations and local reorientation
of the 15NH4
+ ion within the binding site.
The methodology presented above could be further exploit-
ed by combination with the powerful array of existing NMR
techniques to describe the kinetic and dynamic aspects of
MVC binding. For example, employing longitudinal exchange-
type experiments would allow measurement of the exchange
on the millisecond-to-second timescale between two or more
bound MVCs, or the exchange of bound MVCs with those from
the bulk solvent, as has been shown in the context of DNA
quadruplex structures.[8b] The latter experiment depends on de-
tection of bulk ammonium and thus requires a low pH (e.g. ,
pH 5.0),[8b] which might prove a limitation for many proteins. It
would also be intriguing to shed light on the relative mobility
of ammonium ions in the binding sites of enzymes, and 15N,1H-
relaxation-based experiments could give access to such infor-
mation in the future. Given this potential, correlating character-
istics of 15NH4
+ binding with functional enzymatic states, as
exemplified here, will ultimately lead to a better understanding
of the role of monovalent cations in proteins and enzymes.
Experimental Section
Expression and purification of HDAC8: Recombinant HDAC8 was
expressed and purified as described previously.[17] Isotope-labelled
samples were prepared from culture grown in M9 minimal
medium. For the U-15N,1H sample, the M9 medium was made with
15NH4Cl (1 gL
1). For the U-15N,2H sample, the M9 medium was
made up in ~99% D2O with 15NH4Cl (1 gL1) and 2H7-glucose
(2.5 gL1). For the His-15N,1H/U-14N,2H sample, the M9 medium was
made up in ~99% D2O with 14NH4Cl (1 gL1) and 2H7-glucose
(2.5 gL1) ; [15N,1H]histidine (60 mgL1) was added to the culture
1 h prior to induction. Expression was induced with ZnCl2 (0.2 mm)
and isopropyl-b-d-thiogalactopyranoside (1 mm), and growth con-
tinued overnight at 21 8C before harvesting. Typical HDAC8 yields
were 1–2 mg per litre of M9 culture. All isotopes were purchased
from Sigma–Aldrich. Recombinant DnaK-ABD (residues 1–381 of
Thermus thermophilus DnaK) was expressed in 2YT medium from
BL21(DE3) cells and purified essentially as described previously for
DnaK.[18] The yield was approximately 30 mg per litre of 2YT cul-
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ture. The nucleotide content (~2%) of the preparation was deter-
mined by HPLC analysis.
Activity assay: HDAC8 activity was measured by a modified fluo-
rescence-based assay.[19] The substrate analogue Boc-Lys(Ac)-7-
amino-4-methylcoumarin (MAL) was synthesised according to Hoff-
mann et al.[20] and kindly provided by Christopher Matthews and
Charles Marson (UCL, London). The deacetylation reaction was per-
formed in Tris·HCl (25 mm, pH 8.0) with different concentrations of
KCl, NH4Cl and choline chloride. HDAC8 (0.4 mm) was added to
these buffers and incubated for at least 30 min at room tempera-
ture. It should be noted that this addition introduced KCl (final
concentration 1.5 mm) from the enzyme stock. The reaction was
started by adding substrate (200 mm), and quenched after 30 min
at 25 8C by addition of an equal volume of developer solution
(trypsin (10 mgmL1) and trichostatin A (4 mm) in Tris·HCl (50 mm
pH 8.0), NaCl (137 mm), KCl (2.7 mm), MgCl2 (1 mm), PEG (10%,
avg. 8000 Da) and BSA (1 mgmL1)). After incubation at room tem-
perature for 30 min, the degree of relative deacetylation was quan-
tified in a FLUOstar Optima plate reader (excitation: 380 nm, detec-
tion: 460 nm; BMG Labtech, Aylesbury, UK).
NMR experiments: Unless indicated otherwise, samples for NMR
experiments were prepared in Tris·HCl (25 mm, pH 8.0), with TCEP
(0.5 mm), NaN3 (1 mm) and
15NH4Cl (200 mm). The spectra present-
ed in Figure 2 and 3 were measured with an external D2O refer-
ence insert (Wilmad coaxial insert Z278513 (Sigma–Aldrich)), in
which case no D2O was added to the sample buffer. Otherwise,
NMR buffer contained 10% D2O. Protein concentrations were 0.1–
0.3 mm. All 15N-edited proton 1D spectra and the direct-observed
15N 1D spectra were recorded at 298 K on a 500 MHz Avance III
spectrometer (Bruker) equipped with a room temperature, inverse,
triple-resonance probe. The pulse sequence for the 15N-edited
proton 1D spectra was based on the first increment of the fast
15N HSQC sequence.[21] The 15N carrier frequency was at 25 ppm.
15N-edited NOESY spectra were recorded at 298 K on a 700 MHz
Avance III spectrometer (Bruker) equipped with a cryogenic inverse
triple-resonance probe. The pulse sequence for the NOESY spectra
was based on a standard NOESY/15N HSQC sequence,[22] with am-
monium selectivity achieved by a shaped IBurp1 nitrogen pulse
(1714 ms, centred at 25 ppm) in the first INEPT of the 15N HSQC ele-
ment.[23] Broadband 15N decoupling during the indirect proton
chemical shift evolution period was achieved by using an adiabatic
smoothed CHIRP pulse (1000 ms, 30 kHz sweep-width, centred at
100 ppm).[24] The NOESY mixing time was 80 ms. Data were pro-
cessed and visualised by using Topspin (Bruker), nmrDraw[25] and
Sparky.[26]
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